124 related articles for article (PubMed ID: 17580816)
1. [The role of plasma chemokines in cancer].
Struyf S; Van Damme J
Verh K Acad Geneeskd Belg; 2007; 69(3):149-65. PubMed ID: 17580816
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.
Vandercappellen J; Noppen S; Verbeke H; Put W; Conings R; Gouwy M; Schutyser E; Proost P; Sciot R; Geboes K; Opdenakker G; Van Damme J; Struyf S
J Leukoc Biol; 2007 Dec; 82(6):1519-30. PubMed ID: 17827342
[TBL] [Abstract][Full Text] [Related]
3. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.
Struyf S; Burdick MD; Peeters E; Van den Broeck K; Dillen C; Proost P; Van Damme J; Strieter RM
Cancer Res; 2007 Jun; 67(12):5940-8. PubMed ID: 17575164
[TBL] [Abstract][Full Text] [Related]
4. Chemokine-protease interactions in cancer.
Van Damme J; Struyf S; Opdenakker G
Semin Cancer Biol; 2004 Jun; 14(3):201-8. PubMed ID: 15246056
[TBL] [Abstract][Full Text] [Related]
5. The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.
Vandercappellen J; Van Damme J; Struyf S
Cytokine Growth Factor Rev; 2011 Feb; 22(1):1-18. PubMed ID: 21111666
[TBL] [Abstract][Full Text] [Related]
6. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.
Opdenakker G; Van Damme J
Int J Dev Biol; 2004; 48(5-6):519-27. PubMed ID: 15349826
[TBL] [Abstract][Full Text] [Related]
7. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
8. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
Iwamoto T; Okamoto H; Toyama Y; Momohara S
FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305
[TBL] [Abstract][Full Text] [Related]
9. PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.
Struyf S; Schutyser E; Gouwy M; Gijsbers K; Proost P; Benoit Y; Opdenakker G; Van Damme J; Laureys G
Am J Pathol; 2003 Nov; 163(5):2065-75. PubMed ID: 14578205
[TBL] [Abstract][Full Text] [Related]
10. The multifaceted roles of chemokines in malignancy.
Ben-Baruch A
Cancer Metastasis Rev; 2006 Sep; 25(3):357-71. PubMed ID: 17016763
[TBL] [Abstract][Full Text] [Related]
11. The chemokine network: a target in cancer biology?
Slettenaar VI; Wilson JL
Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
[TBL] [Abstract][Full Text] [Related]
12. The role of chemokines in cancer immune surveillance by the adaptive immune system.
Krieg C; Boyman O
Semin Cancer Biol; 2009 Apr; 19(2):76-83. PubMed ID: 19038343
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
Koizumi K; Hojo S; Akashi T; Yasumoto K; Saiki I
Cancer Sci; 2007 Nov; 98(11):1652-8. PubMed ID: 17894551
[TBL] [Abstract][Full Text] [Related]
14. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
Soria G; Ben-Baruch A
Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory chemokines in cancer growth and progression.
Rollins BJ
Eur J Cancer; 2006 Apr; 42(6):760-7. PubMed ID: 16510278
[TBL] [Abstract][Full Text] [Related]
16. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
17. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment.
O'Hayre M; Salanga CL; Handel TM; Allen SJ
Biochem J; 2008 Feb; 409(3):635-49. PubMed ID: 18177271
[TBL] [Abstract][Full Text] [Related]
18. Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects.
Struyf S; Proost P; Vandercappellen J; Dempe S; Noyens B; Nelissen S; Gouwy M; Locati M; Opdenakker G; Dinsart C; Van Damme J
Eur J Immunol; 2009 Mar; 39(3):843-57. PubMed ID: 19224633
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory effect of low-dose radiation therapy involves a diminished CCL20 chemokine expression and granulocyte/endothelial cell adhesion.
Rödel F; Hofmann D; Auer J; Keilholz L; Röllinghoff M; Sauer R; Beuscher HU
Strahlenther Onkol; 2008 Jan; 184(1):41-7. PubMed ID: 18188522
[TBL] [Abstract][Full Text] [Related]
20. The role of CXC chemokines and their receptors in cancer.
Vandercappellen J; Van Damme J; Struyf S
Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
